NDC product
ABREVA Rapid Pain Relief
NDC 0135-0400 · Haleon US Holdings LLC
Key facts
| Product NDC | 0135-0400 |
|---|---|
| Proprietary name | ABREVA |
| Nonproprietary name | glycerin, lidocaine |
| Substances | GLYCERIN, LIDOCAINE HYDROCHLORIDE |
| Dosage form | GEL |
| Route | TOPICAL |
| Labeler | Haleon US Holdings LLC |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M017 |
| Pharmacologic classes | Allergens [CS], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Cell-mediated Immunity [PE], Glycerol [CS] and 4 more |
| Marketing start | Jun 1, 2023 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: